Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Weedon

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
Nestle Nutrition Institute Workshop Series|March 19, 2013
Genome-wide association studies of human growth traitsMichael N Weedon
Trends in Genetics : TIG|October 28, 2008
Reaching new heights: insights into the genetics of human statureMichael N Weedon, Timothy M Frayling
Current Diabetes Reports|April 12, 2007
Insights on pathogenesis of type 2 diabetes from MODY geneticsMichael N Weedon, Timothy M Frayling
Biomedical Physics & Engineering Express|February 28, 2025
Exploring the application of deep learning methods for polygenic risk score estimationSteven Squires, Michael N Weedon, Richard A Oram
Bioinformatics Advances|July 18, 2025
Calculating genetic risk scores directly from summary statistics with an application to type 1 diabetesSteven Squires, Michael N Weedon, Richard A Oram
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Exploring the application of deep learning methods for polygenic risk score estimationSteven Squires, Michael N Weedon, Richard A Oram
In Vivo (Athens, Greece)|March 4, 2022
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in EnglandKinan Mokbel, Rob Daniels, Michael N Weedon, et al.
Clinical Endocrinology|December 18, 2003
Tall stories: the fundamental difficulties of genetic association studiesMichael N Weedon, Andrew T Hattersley, Timothy M Frayling
Cell|April 2, 2021
Unreliability of genotyping arrays for detecting very rare variants in human genetic studies: Example from a recent study of MC4RMichael N Weedon, Caroline F Wright, Kashyap A Patel, et al.
NPJ Breast Cancer|February 26, 2026
No evidence for genotype-treatment interactions with breast cancer endocrine therapy adverse effects in UK BiobankKinan Mokbel, Michael N Weedon, Victoria Moye, et al.
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
Nestle Nutrition Institute Workshop Series|March 19, 2013
Genome-wide association studies of human growth traitsMichael N Weedon
Trends in Genetics : TIG|October 28, 2008
Reaching new heights: insights into the genetics of human statureMichael N Weedon, Timothy M Frayling
Current Diabetes Reports|April 12, 2007
Insights on pathogenesis of type 2 diabetes from MODY geneticsMichael N Weedon, Timothy M Frayling
Biomedical Physics & Engineering Express|February 28, 2025
Exploring the application of deep learning methods for polygenic risk score estimationSteven Squires, Michael N Weedon, Richard A Oram
Bioinformatics Advances|July 18, 2025
Calculating genetic risk scores directly from summary statistics with an application to type 1 diabetesSteven Squires, Michael N Weedon, Richard A Oram
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Exploring the application of deep learning methods for polygenic risk score estimationSteven Squires, Michael N Weedon, Richard A Oram
In Vivo (Athens, Greece)|March 4, 2022
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in EnglandKinan Mokbel, Rob Daniels, Michael N Weedon, et al.
Clinical Endocrinology|December 18, 2003
Tall stories: the fundamental difficulties of genetic association studiesMichael N Weedon, Andrew T Hattersley, Timothy M Frayling
Cell|April 2, 2021
Unreliability of genotyping arrays for detecting very rare variants in human genetic studies: Example from a recent study of MC4RMichael N Weedon, Caroline F Wright, Kashyap A Patel, et al.
NPJ Breast Cancer|February 26, 2026
No evidence for genotype-treatment interactions with breast cancer endocrine therapy adverse effects in UK BiobankKinan Mokbel, Michael N Weedon, Victoria Moye, et al.
Pageof 26